The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Clinical evaluation and management of myasthenia gravis
Abstract
Myasthenia gravis (MG) is a syndrome of fluctuating skeletal muscle weakness that worsens with use and improves with rest. Eye, facial, oropharyngeal, axial, and limb muscles may be involved in varying combinations and degrees of severity. Its etiology is heterogeneous, divided initially between those rare congenital myasthenic syndromes, which are genetic, and the bulk of MG, which is acquired and autoimmune. The autoimmune conditions are divided in turn between those that possess measurable serum acetylcholine receptor (AChR) antibodies and a smaller group that does not. The latter group includes those MG patients who have serum antibodies to muscle‐specific tyrosine kinase (MuSK). Therapeutic considerations differ for early‐onset MG, late‐onset MG, and MG associated with the presence of a thymoma. Most MG patients can be treated effectively, but there is still a need for more specific immunological approaches. Muscle Nerve 29: 484–505, 2004
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oosterhuis, H. (1997) · Cited by 2,397
Myasthenia gravis: Recommendations for clinical research standards
Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America, Jaretzki, A., Barohn, R. J., Ernstoff, R. M., Kaminski, H. J., Keesey, J. C., Penn, A. S., & Sanders, D. B. (2000) · Neurology · doi:10.1212/wnl.55.1.16 · Cited by 1,651
Self-citationLINDSTROM, J. M., SEYBOLD, M. E., LENNON, V. A., WHITTINGHAM, S., & DUANE, D. D. (1976) · Neurology · doi:10.1212/wnl.26.11.1054 · Cited by 1,186
Hoch, W., McConville, J., Helms, S., Newsom-Davis, J., Melms, A., & Vincent, A. (2001) · Nature Medicine · doi:10.1038/85520 · Cited by 1,183
Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors
Fambrough, D. M., Drachman, D. B., & Satyamurti, S. (1973) · Science · doi:10.1126/science.182.4109.293 · Cited by 640
Myasthenia Gravis: A New Hypothesis
Simpson, J. A. (1960) · Scottish Medical Journal · doi:10.1177/003693306000501001 · Cited by 583
Gronseth, G. S., & Barohn, R. J. (2000) · Neurology · doi:10.1212/wnl.55.1.7 · Cited by 576
Wessely, S., & Powell, R. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.8.940 · Cited by 481
A randomized double‐blind trial of prednisolone alone or with azathioprine in myasthenia gravis
Palace, J., Newsom-Davis, J., Lecky, B., & Myasthenia Gravis Study Group (1998) · Neurology · doi:10.1212/wnl.50.6.1778 · Cited by 473
Myasthenia Gravis: Study of Humoral Immune Mechanisms by Passive Transfer to Mice
Toyka, K. V., Drachman, D. B., Griffin, D. E., Pestronk, A., Winkelstein, J. A., Fischbeck, K. H., & Kao, I. (1977) · New England Journal of Medicine · doi:10.1056/nejm197701202960301 · Cited by 436
Reliability Testing of the Quantitative Myasthenia Gravis Scorea
BAROHN, R. J., McINTIRE, D., HERBELIN, L., WOLFE, G. I., NATIONS, S., & BRYAN, W. W. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb11015.x · Cited by 417
Clinical aspects of MuSK antibody positive seronegative MG
Sanders, D. B., El-Salem, K., Massey, J. M., McConville, J., & Vincent, A. (2003) · Neurology · doi:10.1212/01.wnl.0000065882.63904.53 · Cited by 407
Tindall, R. S. A., Rollins, J. A., Phillips, J. T., Greenlee, R. G., Wells, L., & Belendiuk, G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703193161205 · Cited by 394
ACUTE ANTERIOR UVEITIS AND HL-A 27
Brewerton, D. A., Caffrey, M., Nicholls, A., Walters, D., & James, D. C. O. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92431-3 · Cited by 366
Long‐term corticosteriod treatment of myasthenia gravis: Report of 116 Patients
Pascuzzi, R. M., Coslett, H. B., & Johns, T. R. (1984) · Annals of Neurology · doi:10.1002/ana.410150316 · Cited by 333
The natural course of myasthenia gravis: a long term follow up study.
Oosterhuis, H. J. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.10.1121 · Cited by 326
Engel, A. G., Lambert, E. H., Mulder, D. M., Torres, C. F., Sahashi, K., Bertorini, T. E., & Whitaker, J. N. (1982) · Annals of Neurology · doi:10.1002/ana.410110603 · Cited by 263
Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases
Chaudhry, V., Cornblath, D. R., Griffin, J. W., O’Brien, R., & Drachman, D. B. (2001) · Neurology · doi:10.1212/wnl.56.1.94 · Cited by 259
The Epidemiology of Myasthenia Gravis
PHILLIPS, L. H. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1254.053 · Cited by 250
Experimental Staphylococcus Infection in Man
Foster, W. D., & Hutt, M. S. R. (1960) · RePub (Erasmus University Rotterdam) · Cited by 237
Course and treatment of myasthenia gravis during pregnancy
Batocchi, A. P., Majolini, L., Evoli, A., Lino, M. M., Minisci, C., & Tonali, P. (1999) · Neurology · doi:10.1212/wnl.52.3.447 · Cited by 211
CRIMEAN-CONGO HAEMORRHAGIC FEVER AND RIFT VALLEY FEVER IN SOUTH-EASTERN MAURITANIA
Saluzzo, J. F., Digoutte, J. P., Camicas, J. L., & Chauvancy, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92014-8 · Cited by 199
Mycophenolate mofetil for myasthenia gravis: An open-label pilot study
Ciafaloni, E., Massey, J. M., Tucker–Lipscomb, B., & Sanders, D. B. (2001) · Neurology · doi:10.1212/wnl.56.1.97 · Cited by 183
The Frequency of the Chronic Fatigue Syndrome in Patients with Symptoms of Persistent Fatigue
Manu, P., Lane, T. J., & Matthews, D. A. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-7-554 · Cited by 155
Westhoff, C. L. (2003) · Contraception · doi:10.1016/s0010-7824(03)00136-7 · Cited by 148
Epidemiology of Myasthenia Gravis in Denmark A Longitudinal and Comprehensive Population Survey
Somnier, F., Keiding, N., & Paulson, O. B. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530190081019 · Cited by 136
Aarli, J. A. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.25 · Cited by 135
Epidemiologic evidence for a changing natural history of myasthenia gravis
Phillips, L. H., & Torner, J. C. (1996) · Neurology · doi:10.1212/wnl.47.5.1233 · Cited by 123
A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy
Mantegazza, R., Beghi, E., Pareyson, D., Antozzi, C. G., Peluchetti, D., Sghirlanzoni, A., Cosi, V., Lombardi, M., Piccolo, G., Tonali, P., et al. (1990) · Journal of Neurology · doi:10.1007/bf00315656 · Cited by 117
Clinical Pharmacology of Systemic Corticosteroids
MELBY, J. C. (1977) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.17.040177.002455 · Cited by 114
Serologic profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome
Lennon, V. A. (1997) · Neurology · doi:10.1212/wnl.48.suppl_5.23s · Cited by 111
Myasthenia Gravis and Myasthenic Disorders
(2012) · Oxford University Press eBooks · doi:10.1093/med/9780199738670.001.0001 · Cited by 104
Mycophenolate mofetil: A unique immunosuppressive agent
Hood, K. A., & Zarembski, D. G. (1997) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/54.3.285 · Cited by 99
Complications of Plasma Exchange in Neurological Patients
Rodnitzky, R. L., & Goeken, J. A. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510180028007 · Cited by 81
Seronegative myasthenia gravis
Sanders, D. B., Andrews, P. I., Howard, J. F., et al. (1997) · Neurology · doi:10.1212/wnl.48.suppl_5.40s · Cited by 76
Nations, S., Wolfe, G. I., Amato, A. A., Jackson, C. E., Bryan, W. W., & Barohn, R. J. (1999) · Neurology · doi:10.1212/wnl.52.3.632 · Cited by 70
Assessment of plasmapheresis [RETIRED]
(1996) · Neurology · doi:10.1212/wnl.47.3.840 · Cited by 67
Does myasthenia gravis affect the brain?
Keesey, J. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00205-1 · Cited by 62
Self-citationČikeš, N., Momoi, M. Y., Williams, C. L., HOWARD, F. M., Hoagland, H. C., Whittingham, S., & Lennon, V. A. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65645-6 · Cited by 55
Wisniewski, A. B., Nguyen, T. T., & Dobs, A. S. (2002) · Hormone Research in Paediatrics · doi:10.1159/000064491 · Cited by 45
The long-term clinical outcome of myasthenia gravis in patients with thymoma
Bril, V., Kojic, J., & Dhanani, A. (1998) · Neurology · doi:10.1212/wnl.51.4.1198 · Cited by 41
Contemporary opinions about Mary Walker
Keesey, J. (1998) · Neurology · doi:10.1212/wnl.51.5.1433 · Cited by 29
Self-citationCognitive Decline in Down Syndrome—Reply
Lott, I. T., Osann, K., Nelson, L. D., & Doran, E. W. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.1024-a · Cited by 16
Thymoma-Associated Myasthenia Gravis
Marx, A., Ströbel, P., & Weis, C.-A. (2003) · Current clinical neurology · doi:10.1007/978-3-032-19140-3_8 · Cited by 7
Target fibers in multiple sclerosis: Implications for pathogenesis
Riggs, J. E., Schochet, S. S., Kopitnik, T. A., & Gutmann, L. (1986) · Neurology · doi:10.1212/wnl.36.2.297 · Cited by 7
Low T cell receptor excision circle levels in patients thymectomized 25–54 years ago
Storek, J., Douek, D. C., Keesey, J., Boehmer, L. N., Storer, B. E., & Maloney, D. G. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00133-0 · Cited by 7
Self-citation
Cited by
Lifetime course of myasthenia gravis
Grob, D., Brunner, N., Namba, T., & Pagala, M. (2008) · Muscle & Nerve · doi:10.1002/mus.20950 · Cited by 733
Myasthenia gravis: past, present, and future
Conti-Fine, B. M., Milani, M., & Kaminski, H. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29894 · Cited by 691
Mechanisms of Autoantibody-Induced Pathology
Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00603 · Cited by 469
Muscle Giants: Molecular Scaffolds in Sarcomerogenesis
Kontrogianni-Konstantopoulos, A., Ackermann, M. A., Bowman, A. L., Yap, S. V., & Bloch, R. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00017.2009 · Cited by 259
Metadata
- Authors
- Keesey, J. C.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2004-03-16
- Volume
- 29
- Issue
- 4
- Pages
- 484-505
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2023275299
- Cited by
- 285
- References
- 46
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.